GlassScriptPhysician profile
Sara Belajonas
NPI 1205164159
$1,685.87
in general payments reported to CMS, 2019-2025
15 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $383 · 2022: $176 · 2023: $241 · 2024: $516 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,019.09 |
| Education | $108.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $581.97 | 2021-2024 | Jardiance |
| Medtronic, INC. | $232.10 | 2024 | Micra |
| Abbott Laboratories | $207.67 | 2024-2025 | Aveir |
| Amgen INC. | $113.97 | 2021-2023 | Repatha |
| Boston Scientific Corporation | $110.74 | 2024-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $94.27 | 2021-2023 | |
| Shockwave Medical, INC | $70.32 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $67.00 | 2022-2024 | Xarelto |
| Impulse Dynamics (USA) INC. | $57.92 | 2025 | Optimizer |
| Altathera Pharmaceuticals LLC | $38.58 | 2025 | Sotalol Hydrochloride |
| Pfizer INC. | $33.66 | 2023 | |
| Philips North America LLC | $32.40 | 2024 | (5044) Mcot |
| Phathom Pharmaceuticals, INC. | $17.30 | 2025 | Voquezna |
| Alexion Pharmaceuticals, INC. | $14.45 | 2021 | |
| Chiesi USA, INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Belajonas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.